Biomatter
Lithuania · Biotech · AI
Biomatter designs custom enzymes for pharmaceutical, diagnostic, agricultural and industrial applications.
Product
Biomatter combines computational models with laboratory experiments to design enzymes for a customer’s target chemical reaction. Its development work starts with the required chemistry and tests whether the resulting enzyme performs under practical conditions.
Product and customers
The company’s platform draws on an expanding dataset of experimentally characterised enzymes. Based in Vilnius, Biomatter works with enterprise customers across Europe, the United States and Japan.
Biomatter’s custom-enzyme products in the laboratory.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | $18M | Astanor — LeadInventure — ParticipantMetaplanet — ParticipantUVC Partners — Participant |